HEADER MEMBRANE PROTEIN 06-MAR-20 6Y90 TITLE STRUCTURE OF FULL-LENGTH CD20 IN COMPLEX WITH RITUXIMAB FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-LYMPHOCYTE ANTIGEN CD20; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: B-LYMPHOCYTE SURFACE ANTIGEN B1,BP35,LEUKOCYTE SURFACE COMPND 5 ANTIGEN LEU-16,MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: FULL-LENGTH WILD TYPE HUMAN CD20; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: RITUXIMAB FAB HEAVY CHAIN; COMPND 10 CHAIN: C, H; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: RITUXIMAB FAB LIGHT CHAIN; COMPND 14 CHAIN: D, L; COMPND 15 ENGINEERED: YES; COMPND 16 OTHER_DETAILS: RITUXIMAB LIGHT CHAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: B-LYMPHOCYTE; SOURCE 6 GENE: MS4A1, CD20; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: HEK-293F; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PCDNA3.1+; SOURCE 13 MOL_ID: 2; SOURCE 14 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 15 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 16 ORGANISM_TAXID: 10090; SOURCE 17 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 18 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: HEK-293F; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: IGG1 EXPRESSION VECTOR; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 25 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 26 ORGANISM_TAXID: 10090; SOURCE 27 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 28 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 29 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 30 EXPRESSION_SYSTEM_CELL_LINE: HEK-293F; SOURCE 31 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 32 EXPRESSION_SYSTEM_PLASMID: IGG1 EXPRESSION VECTOR KEYWDS CANCER IMMUNOTHERAPY, THERAPEUTIC ANTIBODY, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR A.KUMAR,N.REYES REVDAT 1 26-AUG-20 6Y90 0 JRNL AUTH A.KUMAR,C.PLANCHAIS,R.FRONZES,H.MOUQUET,N.REYES JRNL TITL BINDING MECHANISMS OF THERAPEUTIC ANTIBODIES TO HUMAN CD20. JRNL REF SCIENCE V. 369 793 2020 JRNL REFN ESSN 1095-9203 JRNL PMID 32792392 JRNL DOI 10.1126/SCIENCE.ABB8008 REMARK 2 REMARK 2 RESOLUTION. 3.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : SERIALEM, GCTF, UCSF CHIMERA, COOT, REMARK 3 PHENIX, CRYOSPARC, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 2OSL REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : AB INITIO MODEL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : THE CD20-RITUXIMAB FAB MODEL WAS BUILT BY REMARK 3 PLACING CD20 PEPTIDE (RESIDUES 167-186) AND RITUXIMAB FAB FROM REMARK 3 PDB 2OSL INTO THE EM MAP. THE INITIAL MODEL WAS FITTED MANUALLY REMARK 3 AND EXTENDED TO A FULL CD20 MODEL ENCOMPASSING RESIDUES 45-216. REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.690 REMARK 3 NUMBER OF PARTICLES : 65203 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 6Y90 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1292107085. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : FULL-LENGTH HUMAN ANTIGEN CD20 REMARK 245 IN COMPLEX WITH RITUXIMAB FAB; REMARK 245 FULL-LENGTH HUMAN CD20; REMARK 245 RITUXIMAB FAB REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.50 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 9263 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 41.30 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 22170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -113.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR D 50 -9.00 71.32 REMARK 500 PRO D 140 -158.75 -79.48 REMARK 500 THR L 50 -8.90 71.28 REMARK 500 PRO L 140 -158.70 -79.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 Y01 A 303 REMARK 610 PC1 A 304 REMARK 610 Y01 B 304 REMARK 610 PC1 B 305 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PC1 A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYS A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYS A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 A 310 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 B 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PC1 B 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYS B 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYS B 309 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-10731 RELATED DB: EMDB REMARK 900 STRUCTURE OF FULL-LENGTH CD20 IN COMPLEX WITH RITUXIMAB FAB REMARK 900 RELATED ID: EMD-10732 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-10733 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-10734 RELATED DB: EMDB DBREF 6Y90 A 45 216 UNP P11836 CD20_HUMAN 45 216 DBREF 6Y90 B 45 216 UNP P11836 CD20_HUMAN 45 216 DBREF 6Y90 C 1 224 PDB 6Y90 6Y90 1 224 DBREF 6Y90 D 1 213 PDB 6Y90 6Y90 1 213 DBREF 6Y90 H 1 224 PDB 6Y90 6Y90 1 224 DBREF 6Y90 L 1 213 PDB 6Y90 6Y90 1 213 SEQRES 1 A 172 PHE MET ARG GLU SER LYS THR LEU GLY ALA VAL GLN ILE SEQRES 2 A 172 MET ASN GLY LEU PHE HIS ILE ALA LEU GLY GLY LEU LEU SEQRES 3 A 172 MET ILE PRO ALA GLY ILE TYR ALA PRO ILE CYS VAL THR SEQRES 4 A 172 VAL TRP TYR PRO LEU TRP GLY GLY ILE MET TYR ILE ILE SEQRES 5 A 172 SER GLY SER LEU LEU ALA ALA THR GLU LYS ASN SER ARG SEQRES 6 A 172 LYS CYS LEU VAL LYS GLY LYS MET ILE MET ASN SER LEU SEQRES 7 A 172 SER LEU PHE ALA ALA ILE SER GLY MET ILE LEU SER ILE SEQRES 8 A 172 MET ASP ILE LEU ASN ILE LYS ILE SER HIS PHE LEU LYS SEQRES 9 A 172 MET GLU SER LEU ASN PHE ILE ARG ALA HIS THR PRO TYR SEQRES 10 A 172 ILE ASN ILE TYR ASN CYS GLU PRO ALA ASN PRO SER GLU SEQRES 11 A 172 LYS ASN SER PRO SER THR GLN TYR CYS TYR SER ILE GLN SEQRES 12 A 172 SER LEU PHE LEU GLY ILE LEU SER VAL MET LEU ILE PHE SEQRES 13 A 172 ALA PHE PHE GLN GLU LEU VAL ILE ALA GLY ILE VAL GLU SEQRES 14 A 172 ASN GLU TRP SEQRES 1 B 172 PHE MET ARG GLU SER LYS THR LEU GLY ALA VAL GLN ILE SEQRES 2 B 172 MET ASN GLY LEU PHE HIS ILE ALA LEU GLY GLY LEU LEU SEQRES 3 B 172 MET ILE PRO ALA GLY ILE TYR ALA PRO ILE CYS VAL THR SEQRES 4 B 172 VAL TRP TYR PRO LEU TRP GLY GLY ILE MET TYR ILE ILE SEQRES 5 B 172 SER GLY SER LEU LEU ALA ALA THR GLU LYS ASN SER ARG SEQRES 6 B 172 LYS CYS LEU VAL LYS GLY LYS MET ILE MET ASN SER LEU SEQRES 7 B 172 SER LEU PHE ALA ALA ILE SER GLY MET ILE LEU SER ILE SEQRES 8 B 172 MET ASP ILE LEU ASN ILE LYS ILE SER HIS PHE LEU LYS SEQRES 9 B 172 MET GLU SER LEU ASN PHE ILE ARG ALA HIS THR PRO TYR SEQRES 10 B 172 ILE ASN ILE TYR ASN CYS GLU PRO ALA ASN PRO SER GLU SEQRES 11 B 172 LYS ASN SER PRO SER THR GLN TYR CYS TYR SER ILE GLN SEQRES 12 B 172 SER LEU PHE LEU GLY ILE LEU SER VAL MET LEU ILE PHE SEQRES 13 B 172 ALA PHE PHE GLN GLU LEU VAL ILE ALA GLY ILE VAL GLU SEQRES 14 B 172 ASN GLU TRP SEQRES 1 C 224 GLN VAL GLN LEU GLN GLN PRO GLY ALA GLU LEU VAL LYS SEQRES 2 C 224 PRO GLY ALA SER VAL LYS MET SER CYS LYS ALA SER GLY SEQRES 3 C 224 TYR THR PHE THR SER TYR ASN MET HIS TRP VAL LYS GLN SEQRES 4 C 224 THR PRO GLY ARG GLY LEU GLU TRP ILE GLY ALA ILE TYR SEQRES 5 C 224 PRO GLY ASN GLY ASP THR SER TYR ASN GLN LYS PHE LYS SEQRES 6 C 224 GLY LYS ALA THR LEU THR ALA ASP LYS SER SER SER THR SEQRES 7 C 224 ALA TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 C 224 ALA VAL TYR TYR CYS ALA ARG SER THR TYR TYR GLY GLY SEQRES 9 C 224 ASP TRP TYR PHE ASN VAL TRP GLY ALA GLY THR THR VAL SEQRES 10 C 224 THR VAL SER ALA ALA SER THR LYS GLY PRO SER VAL PHE SEQRES 11 C 224 PRO LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR SEQRES 12 C 224 ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU SEQRES 13 C 224 PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER SEQRES 14 C 224 GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY SEQRES 15 C 224 LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SEQRES 16 C 224 SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS SEQRES 17 C 224 LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO SEQRES 18 C 224 LYS SER CYS SEQRES 1 D 213 GLN ILE VAL LEU SER GLN SER PRO ALA ILE LEU SER ALA SEQRES 2 D 213 SER PRO GLY GLU LYS VAL THR MET THR CYS ARG ALA SER SEQRES 3 D 213 SER SER VAL SER TYR ILE HIS TRP PHE GLN GLN LYS PRO SEQRES 4 D 213 GLY SER SER PRO LYS PRO TRP ILE TYR ALA THR SER ASN SEQRES 5 D 213 LEU ALA SER GLY VAL PRO VAL ARG PHE SER GLY SER GLY SEQRES 6 D 213 SER GLY THR SER TYR SER LEU THR ILE SER ARG VAL GLU SEQRES 7 D 213 ALA GLU ASP ALA ALA THR TYR TYR CYS GLN GLN TRP THR SEQRES 8 D 213 SER ASN PRO PRO THR PHE GLY GLY GLY THR LYS LEU GLU SEQRES 9 D 213 ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE PHE SEQRES 10 D 213 PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SER SEQRES 11 D 213 VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU ALA SEQRES 12 D 213 LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER GLY SEQRES 13 D 213 ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS ASP SEQRES 14 D 213 SER THR TYR SER LEU SER SER THR LEU THR LEU SER LYS SEQRES 15 D 213 ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU VAL SEQRES 16 D 213 THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER PHE SEQRES 17 D 213 ASN ARG GLY GLU CYS SEQRES 1 H 224 GLN VAL GLN LEU GLN GLN PRO GLY ALA GLU LEU VAL LYS SEQRES 2 H 224 PRO GLY ALA SER VAL LYS MET SER CYS LYS ALA SER GLY SEQRES 3 H 224 TYR THR PHE THR SER TYR ASN MET HIS TRP VAL LYS GLN SEQRES 4 H 224 THR PRO GLY ARG GLY LEU GLU TRP ILE GLY ALA ILE TYR SEQRES 5 H 224 PRO GLY ASN GLY ASP THR SER TYR ASN GLN LYS PHE LYS SEQRES 6 H 224 GLY LYS ALA THR LEU THR ALA ASP LYS SER SER SER THR SEQRES 7 H 224 ALA TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 H 224 ALA VAL TYR TYR CYS ALA ARG SER THR TYR TYR GLY GLY SEQRES 9 H 224 ASP TRP TYR PHE ASN VAL TRP GLY ALA GLY THR THR VAL SEQRES 10 H 224 THR VAL SER ALA ALA SER THR LYS GLY PRO SER VAL PHE SEQRES 11 H 224 PRO LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR SEQRES 12 H 224 ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU SEQRES 13 H 224 PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER SEQRES 14 H 224 GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY SEQRES 15 H 224 LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SEQRES 16 H 224 SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS SEQRES 17 H 224 LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO SEQRES 18 H 224 LYS SER CYS SEQRES 1 L 213 GLN ILE VAL LEU SER GLN SER PRO ALA ILE LEU SER ALA SEQRES 2 L 213 SER PRO GLY GLU LYS VAL THR MET THR CYS ARG ALA SER SEQRES 3 L 213 SER SER VAL SER TYR ILE HIS TRP PHE GLN GLN LYS PRO SEQRES 4 L 213 GLY SER SER PRO LYS PRO TRP ILE TYR ALA THR SER ASN SEQRES 5 L 213 LEU ALA SER GLY VAL PRO VAL ARG PHE SER GLY SER GLY SEQRES 6 L 213 SER GLY THR SER TYR SER LEU THR ILE SER ARG VAL GLU SEQRES 7 L 213 ALA GLU ASP ALA ALA THR TYR TYR CYS GLN GLN TRP THR SEQRES 8 L 213 SER ASN PRO PRO THR PHE GLY GLY GLY THR LYS LEU GLU SEQRES 9 L 213 ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE PHE SEQRES 10 L 213 PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SER SEQRES 11 L 213 VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU ALA SEQRES 12 L 213 LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER GLY SEQRES 13 L 213 ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS ASP SEQRES 14 L 213 SER THR TYR SER LEU SER SER THR LEU THR LEU SER LYS SEQRES 15 L 213 ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU VAL SEQRES 16 L 213 THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER PHE SEQRES 17 L 213 ASN ARG GLY GLU CYS HET Y01 A 301 35 HET Y01 A 302 35 HET Y01 A 303 34 HET PC1 A 304 42 HET MYS A 305 15 HET MYS A 306 15 HET MYS A 307 15 HET MYS A 308 15 HET MYS A 309 15 HET Y01 A 310 35 HET Y01 B 301 35 HET Y01 B 302 35 HET Y01 B 303 35 HET Y01 B 304 34 HET PC1 B 305 42 HET MYS B 306 15 HET MYS B 307 15 HET MYS B 308 15 HET MYS B 309 15 HET MYS B 310 15 HETNAM Y01 CHOLESTEROL HEMISUCCINATE HETNAM PC1 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE HETNAM MYS PENTADECANE HETSYN PC1 3-SN-PHOSPHATIDYLCHOLINE FORMUL 7 Y01 8(C31 H50 O4) FORMUL 10 PC1 2(C44 H88 N O8 P) FORMUL 11 MYS 10(C15 H32) HELIX 1 AA1 GLU A 48 LEU A 70 1 23 HELIX 2 AA2 PRO A 79 VAL A 84 1 6 HELIX 3 AA3 TRP A 85 ALA A 102 1 18 HELIX 4 AA4 LEU A 112 ILE A 143 1 32 HELIX 5 AA5 LEU A 152 ALA A 157 1 6 HELIX 6 AA6 ASN A 171 LYS A 175 5 5 HELIX 7 AA7 SER A 177 GLU A 215 1 39 HELIX 8 AA8 GLU B 48 MET B 71 1 24 HELIX 9 AA9 PRO B 79 VAL B 84 1 6 HELIX 10 AB1 TRP B 85 ALA B 102 1 18 HELIX 11 AB2 LEU B 112 ILE B 143 1 32 HELIX 12 AB3 LEU B 152 ALA B 157 1 6 HELIX 13 AB4 ASN B 171 LYS B 175 5 5 HELIX 14 AB5 SER B 177 GLU B 215 1 39 HELIX 15 AB6 GLU D 78 ALA D 82 5 5 HELIX 16 AB7 SER D 120 GLY D 127 1 8 HELIX 17 AB8 SER D 181 HIS D 188 1 8 HELIX 18 AB9 GLU L 78 ALA L 82 5 5 HELIX 19 AC1 SER L 120 GLY L 127 1 8 HELIX 20 AC2 SER L 181 HIS L 188 1 8 SHEET 1 AA1 4 GLN C 3 GLN C 5 0 SHEET 2 AA1 4 VAL C 18 SER C 25 -1 O LYS C 23 N GLN C 5 SHEET 3 AA1 4 THR C 78 LEU C 83 -1 O MET C 81 N MET C 20 SHEET 4 AA1 4 ALA C 68 ASP C 73 -1 N THR C 71 O TYR C 80 SHEET 1 AA2 2 LEU C 11 VAL C 12 0 SHEET 2 AA2 2 THR C 118 VAL C 119 1 O THR C 118 N VAL C 12 SHEET 1 AA3 5 THR C 58 SER C 59 0 SHEET 2 AA3 5 GLY C 44 ILE C 51 -1 N ALA C 50 O SER C 59 SHEET 3 AA3 5 TRP C 36 THR C 40 -1 N LYS C 38 O GLU C 46 SHEET 4 AA3 5 VAL C 93 CYS C 96 -1 O VAL C 93 N GLN C 39 SHEET 5 AA3 5 THR C 115 THR C 116 -1 O THR C 115 N TYR C 94 SHEET 1 AA4 2 THR C 100 TYR C 102 0 SHEET 2 AA4 2 ASP C 105 TYR C 107 -1 O TYR C 107 N THR C 100 SHEET 1 AA5 4 SER C 128 LEU C 132 0 SHEET 2 AA5 4 THR C 143 TYR C 153 -1 O LEU C 149 N PHE C 130 SHEET 3 AA5 4 TYR C 184 PRO C 193 -1 O VAL C 192 N ALA C 144 SHEET 4 AA5 4 VAL C 171 LEU C 178 -1 N PHE C 174 O SER C 187 SHEET 1 AA6 3 THR C 159 VAL C 160 0 SHEET 2 AA6 3 ILE C 203 HIS C 208 -1 O ASN C 207 N THR C 159 SHEET 3 AA6 3 THR C 213 LYS C 218 -1 O VAL C 215 N VAL C 206 SHEET 1 AA7 4 LEU D 4 SER D 7 0 SHEET 2 AA7 4 VAL D 19 ALA D 25 -1 O ARG D 24 N SER D 5 SHEET 3 AA7 4 SER D 69 ILE D 74 -1 O TYR D 70 N CYS D 23 SHEET 4 AA7 4 PHE D 61 SER D 64 -1 N SER D 62 O THR D 73 SHEET 1 AA8 6 ILE D 10 ALA D 13 0 SHEET 2 AA8 6 THR D 101 ILE D 105 1 O GLU D 104 N ALA D 13 SHEET 3 AA8 6 THR D 84 GLN D 89 -1 N TYR D 85 O THR D 101 SHEET 4 AA8 6 ILE D 32 GLN D 37 -1 N PHE D 35 O TYR D 86 SHEET 5 AA8 6 LYS D 44 TYR D 48 -1 O ILE D 47 N TRP D 34 SHEET 6 AA8 6 ASN D 52 LEU D 53 -1 O ASN D 52 N TYR D 48 SHEET 1 AA9 4 SER D 113 PHE D 117 0 SHEET 2 AA9 4 ALA D 129 ASN D 136 -1 O LEU D 134 N PHE D 115 SHEET 3 AA9 4 LEU D 174 LEU D 180 -1 O LEU D 178 N VAL D 131 SHEET 4 AA9 4 SER D 158 VAL D 162 -1 N SER D 161 O SER D 175 SHEET 1 AB1 4 ALA D 152 GLN D 154 0 SHEET 2 AB1 4 LYS D 144 VAL D 149 -1 N VAL D 149 O ALA D 152 SHEET 3 AB1 4 TYR D 191 THR D 196 -1 O GLU D 194 N GLN D 146 SHEET 4 AB1 4 THR D 205 PHE D 208 -1 O PHE D 208 N TYR D 191 SHEET 1 AB2 4 GLN H 3 GLN H 5 0 SHEET 2 AB2 4 VAL H 18 SER H 25 -1 O LYS H 23 N GLN H 5 SHEET 3 AB2 4 THR H 78 LEU H 83 -1 O MET H 81 N MET H 20 SHEET 4 AB2 4 ALA H 68 ASP H 73 -1 N THR H 71 O TYR H 80 SHEET 1 AB3 2 LEU H 11 VAL H 12 0 SHEET 2 AB3 2 THR H 118 VAL H 119 1 O THR H 118 N VAL H 12 SHEET 1 AB4 5 THR H 58 SER H 59 0 SHEET 2 AB4 5 GLY H 44 ILE H 51 -1 N ALA H 50 O SER H 59 SHEET 3 AB4 5 TRP H 36 THR H 40 -1 N LYS H 38 O GLU H 46 SHEET 4 AB4 5 VAL H 93 CYS H 96 -1 O VAL H 93 N GLN H 39 SHEET 5 AB4 5 THR H 115 THR H 116 -1 O THR H 115 N TYR H 94 SHEET 1 AB5 2 THR H 100 TYR H 102 0 SHEET 2 AB5 2 ASP H 105 TYR H 107 -1 O TYR H 107 N THR H 100 SHEET 1 AB6 4 SER H 128 LEU H 132 0 SHEET 2 AB6 4 THR H 143 TYR H 153 -1 O LEU H 149 N PHE H 130 SHEET 3 AB6 4 TYR H 184 PRO H 193 -1 O VAL H 192 N ALA H 144 SHEET 4 AB6 4 VAL H 171 LEU H 178 -1 N PHE H 174 O SER H 187 SHEET 1 AB7 3 THR H 159 VAL H 160 0 SHEET 2 AB7 3 ILE H 203 HIS H 208 -1 O ASN H 207 N THR H 159 SHEET 3 AB7 3 THR H 213 LYS H 218 -1 O VAL H 215 N VAL H 206 SHEET 1 AB8 4 LEU L 4 SER L 7 0 SHEET 2 AB8 4 VAL L 19 ALA L 25 -1 O ARG L 24 N SER L 5 SHEET 3 AB8 4 SER L 69 ILE L 74 -1 O TYR L 70 N CYS L 23 SHEET 4 AB8 4 PHE L 61 SER L 64 -1 N SER L 62 O THR L 73 SHEET 1 AB9 6 ILE L 10 ALA L 13 0 SHEET 2 AB9 6 THR L 101 ILE L 105 1 O GLU L 104 N ALA L 13 SHEET 3 AB9 6 THR L 84 GLN L 89 -1 N TYR L 85 O THR L 101 SHEET 4 AB9 6 ILE L 32 GLN L 37 -1 N PHE L 35 O TYR L 86 SHEET 5 AB9 6 LYS L 44 TYR L 48 -1 O ILE L 47 N TRP L 34 SHEET 6 AB9 6 ASN L 52 LEU L 53 -1 O ASN L 52 N TYR L 48 SHEET 1 AC1 4 SER L 113 PHE L 117 0 SHEET 2 AC1 4 ALA L 129 ASN L 136 -1 O LEU L 134 N PHE L 115 SHEET 3 AC1 4 LEU L 174 LEU L 180 -1 O LEU L 178 N VAL L 131 SHEET 4 AC1 4 SER L 158 VAL L 162 -1 N SER L 161 O SER L 175 SHEET 1 AC2 4 ALA L 152 GLN L 154 0 SHEET 2 AC2 4 LYS L 144 VAL L 149 -1 N VAL L 149 O ALA L 152 SHEET 3 AC2 4 TYR L 191 THR L 196 -1 O GLU L 194 N GLN L 146 SHEET 4 AC2 4 THR L 205 PHE L 208 -1 O PHE L 208 N TYR L 191 SSBOND 1 CYS A 167 CYS A 183 1555 1555 2.03 SSBOND 2 CYS B 167 CYS B 183 1555 1555 2.03 SSBOND 3 CYS C 22 CYS C 96 1555 1555 2.03 SSBOND 4 CYS C 148 CYS C 204 1555 1555 2.03 SSBOND 5 CYS C 224 CYS D 213 1555 1555 2.02 SSBOND 6 CYS D 23 CYS D 87 1555 1555 2.03 SSBOND 7 CYS D 133 CYS D 193 1555 1555 2.03 SSBOND 8 CYS H 22 CYS H 96 1555 1555 2.03 SSBOND 9 CYS H 148 CYS H 204 1555 1555 2.03 SSBOND 10 CYS H 224 CYS L 213 1555 1555 2.04 SSBOND 11 CYS L 23 CYS L 87 1555 1555 2.03 SSBOND 12 CYS L 133 CYS L 193 1555 1555 2.03 LINK CD2 LEU B 61 CAC Y01 B 301 1555 1555 1.50 LINK CD1 ILE B 135 C29 PC1 B 305 1555 1555 1.49 CISPEP 1 PHE C 154 PRO C 155 0 0.15 CISPEP 2 SER D 7 PRO D 8 0 -3.30 CISPEP 3 ASN D 93 PRO D 94 0 -1.37 CISPEP 4 TYR D 139 PRO D 140 0 1.92 CISPEP 5 PHE H 154 PRO H 155 0 0.15 CISPEP 6 SER L 7 PRO L 8 0 -3.24 CISPEP 7 ASN L 93 PRO L 94 0 -1.33 CISPEP 8 TYR L 139 PRO L 140 0 1.99 SITE 1 AC1 7 SER A 188 LEU A 191 GLY A 192 SER A 195 SITE 2 AC1 7 ILE B 64 ALA B 65 Y01 B 303 SITE 1 AC2 4 ILE A 64 LEU A 88 HIS A 158 Y01 B 302 SITE 1 AC3 1 SER A 99 SITE 1 AC4 2 ILE A 135 ILE A 199 SITE 1 AC5 1 ILE A 135 SITE 1 AC6 1 MET A 149 SITE 1 AC7 6 LYS A 50 ILE A 57 LEU A 61 PHE B 45 SITE 2 AC7 6 GLU B 48 PHE B 203 SITE 1 AC8 7 PHE A 45 GLU A 48 ILE A 199 PHE A 203 SITE 2 AC8 7 ILE B 57 LEU B 61 ALA B 103 SITE 1 AC9 6 Y01 A 302 SER B 188 LEU B 191 GLY B 192 SITE 2 AC9 6 SER B 195 ILE B 199 SITE 1 AD1 3 Y01 A 301 MET B 71 HIS B 158 SITE 1 AD2 1 SER B 99 SITE 1 AD3 3 ILE B 135 LYS B 142 ILE B 199 SITE 1 AD4 1 PHE B 146 SITE 1 AD5 1 TRP B 85 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000